Gareen IF - Search Results

1

A qualitative study of lung cancer risk perceptions and smoking beliefs among national lung screening trial participants.

Park ER, Streck JM, Gareen IF, Ostroff JS, Hyland KA, Rigotti NA, Pajolek H, Nichter M. Park ER, et al. Among authors: gareen if. Nicotine Tob Res. 2014 Feb;16(2):166-73. doi: 10.1093/ntr/ntt133. Epub 2013 Sep 2. Nicotine Tob Res. 2014. PMID: 23999653 Free PMC article.

2

Risk perceptions among participants undergoing lung cancer screening: baseline results from the National Lung Screening Trial.

Park ER, Ostroff JS, Rakowski W, Gareen IF, Diefenbach MA, Feibelmann S, Rigotti NA. Park ER, et al. Among authors: gareen if. Ann Behav Med. 2009 Jun;37(3):268-79. doi: 10.1007/s12160-009-9112-9. Epub 2009 Aug 27. Ann Behav Med. 2009. PMID: 19711141 Free PMC article. Clinical Trial.

3

Examining whether lung screening changes risk perceptions: National Lung Screening Trial participants at 1-year follow-up.

Park ER, Gareen IF, Jain A, Ostroff JS, Duan F, Sicks JD, Rakowski W, Diefenbach M, Rigotti NA. Park ER, et al. Among authors: gareen if. Cancer. 2013 Apr 1;119(7):1306-13. doi: 10.1002/cncr.27925. Epub 2012 Dec 20. Cancer. 2013. PMID: 23280348 Free PMC article.

4

Impact of lung cancer screening results on participant health-related quality of life and state anxiety in the National Lung Screening Trial.

Gareen IF, Duan F, Greco EM, Snyder BS, Boiselle PM, Park ER, Fryback D, Gatsonis C. Gareen IF, et al. Cancer. 2014 Nov 1;120(21):3401-9. doi: 10.1002/cncr.28833. Epub 2014 Jul 25. Cancer. 2014. PMID: 25065710 Free PMC article. Clinical Trial.

5

The Relations Between False Positive and Negative Screens and Smoking Cessation and Relapse in the National Lung Screening Trial: Implications for Public Health.

Clark MA, Gorelick JJ, Sicks JD, Park ER, Graham AL, Abrams DB, Gareen IF. Clark MA, et al. Among authors: gareen if. Nicotine Tob Res. 2016 Jan;18(1):17-24. doi: 10.1093/ntr/ntv037. Epub 2015 Mar 6. Nicotine Tob Res. 2016. PMID: 25746779 Free PMC article. Clinical Trial.

6

Primary Care Provider-Delivered Smoking Cessation Interventions and Smoking Cessation Among Participants in the National Lung Screening Trial.

Park ER, Gareen IF, Japuntich S, Lennes I, Hyland K, DeMello S, Sicks JD, Rigotti NA. Park ER, et al. Among authors: gareen if. JAMA Intern Med. 2015 Sep;175(9):1509-16. doi: 10.1001/jamainternmed.2015.2391. JAMA Intern Med. 2015. PMID: 26076313 Free PMC article. Clinical Trial.

7

Racial Differences in Tobacco Cessation and Treatment Usage After Lung Screening: An Examination of the National Lung Screening Trial.

Kumar P, Gareen IF, Lathan C, Sicks JD, Perez GK, Hyland KA, Park ER. Kumar P, et al. Among authors: gareen if. Oncologist. 2016 Jan;21(1):40-9. doi: 10.1634/theoncologist.2015-0325. Epub 2015 Dec 28. Oncologist. 2016. PMID: 26712960 Free PMC article. Clinical Trial.

8

Racial Differences in Smoking-related Disease Risk Perceptions Among Adults Completing Lung Cancer Screening: Follow-up Results from the ACRIN/NLST Ancillary Study.

Perez GK, Gareen IF, Sicks J, Lathan C, Carr A, Kumar P, Ponzani C, Hyland K, Park ER. Perez GK, et al. Among authors: gareen if. J Racial Ethn Health Disparities. 2019 Aug;6(4):676-685. doi: 10.1007/s40615-019-00566-z. Epub 2019 Feb 8. J Racial Ethn Health Disparities. 2019. PMID: 30737732 Free PMC article.

9

Study protocol for a hybrid type 1 effectiveness-implementation trial testing virtual tobacco treatment in oncology practices [Smokefree Support Study 2.0].

Goshe BM, Rasmussen AW, Wagner LI, Sicks JD, Gareen IF, Carlos RC, Herman BA, Walter AW, Regan S, Levy DE, Mahon I, Muzikansky A, Neil JM, Lui M, Dilip D, Malloy L, Gonzalez I, Finkelstein-Fox L, McCann C, Perez E, Ostroff JS, Park ER. Goshe BM, et al. Among authors: gareen if. BMC Public Health. 2022 Jul 15;22(1):1359. doi: 10.1186/s12889-022-13631-w. BMC Public Health. 2022. PMID: 35841024 Free PMC article.

10

Cigarette and Alternative Tobacco Product Use among Adult Cancer Survivors Enrolled in 9 ECOG-ACRIN Clinical Trials.

Streck JM, Lee JW, Walter AW, Rosen RL, Gareen IF, Kircher SM, Herman BA, Carlos RC, Kumar S, Mayer IA, Saba NF, Fenske TS, Neal JW, Atkins MB, Hodi FS, Kyriakopoulos CE, Tempany C, Shanafelt TD, Wagner LI, Land SR, Park ER, Ostroff JS. Streck JM, et al. Among authors: gareen if. Cancer Epidemiol Biomarkers Prev. 2023 Nov 1;32(11):1552-1557. doi: 10.1158/1055-9965.EPI-23-0420. Cancer Epidemiol Biomarkers Prev. 2023. PMID: 37410096 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

68 results

Search Page

Filters